Publications by authors named "Daniel Di Primeo"

Claim this Profile
N
Neratinib Alone or in Combination with Immune Checkpoint Inhibitors with or without Mammalian Target of Rapamycin Inhibitors in Patients with Fibrolamellar Carcinoma.
Ghassan K Abou-Alfa, Tim Meyer, Richard Kinh Gian Do, Sarina A Piha-Paul, Joseph S Light, Daniel DiPrimeo

Liver Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical and clinical evaluation through serial colonoscopic evaluation of neratinib-induced diarrhea in HER2-positive breast cancer-A pilot study.
Joanne Bowen, Sofia Braga, Valeria Dal Zotto, John Finnie, Daniel DiPrimeo

Physiol Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial.
Claire F Friedman, Anishka D'Souza, Diana Bello Roufai, Anna V Tinker, Maria de Miguel, Daniel DiPrimeo

Gynecol Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial.
Frankie A Holmes, Beverly Moy, Suzette Delaloge, Stephen K L Chia, Bent Ejlertsen, Daniel DiPrimeo

Eur J Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer.
Arlene Chan, Manuel Ruiz-Borrego, Gavin Marx, A Jo Chien, Hope S Rugo, Daniel DiPrimeo

Breast· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.
James J Harding, Sarina A Piha-Paul, Ronak H Shah, Jessica J Murphy, James M Cleary, Daniel DiPrimeo

Nat Commun· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of neratinib during co-administration with loperamide in healthy subjects.
Kiana Keyvanjah, Blaire Cooke, David Martin, Daniel Di Primeo, Laura Sterling

Cancer Chemother Pharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of neratinib during coadministration with lansoprazole in healthy subjects.
Kiana Keyvanjah, Daniel DiPrimeo, Ai Li, Mohammad Obaidi, Dennis Swearingen

Br J Clin Pharmacol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
Harold E Paulus, Daniel Di Primeo, John T Sharp, Harry K Genant, Barbara N Weissman

J Rheumatol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis